Integrity Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Integrity Alliance's XBI Position: Q1 2026 in Review
Integrity Alliance increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.2% in Q1 2026, buying an estimated $16.1K and bringing the position to 6,061 shares worth $774K. The position accounts for 0.03% of the portfolio, ranked #348.
Integrity Alliance first reported a position in XBI in Q1 2025 and has held it in 3 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Integrity Alliance held 6,061 shares of State Street SPDR S&P Biotech ETF worth $774K as of Q1 2026.
- Integrity Alliance bought 129 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $16.1K.
- State Street SPDR S&P Biotech ETF made up 0.03% of Integrity Alliance's portfolio in Q1 2026, its #348 holding.
- Integrity Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 3 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.